Strategy's Michael Saylor Blames AI Boom for Bitcoin Slide
Bitcoin has tumbled as the AI boom pulls money into tech and AI-related plays. This article breaks down what capital ...
Which Is Better For 401k Index Fund Or Target Date
Compare 401(k) options by evaluating index funds against target date funds to see which aligns with your retirement plan and risk tolerance.
25,660 articles
Fed’s Hawkish Stance Signals Dollar Shift, Markets Rally
The Fed’s hawkish stance signals a step-change in dollar sentiment as rates stay higher for longer, reshaping investm...
XYLD Versus SPY: The 28% Price Gap Explained
Investors face a 28% price return gap between XYLD and SPY as income-focused strategy meets growth potential. This re...
Bear Market Bottom When Bitcoin Targets New High Above 126K
Bitcoin hovers around 82,000 as traders assess whether the bear market bottom when will be confirmed. A sustained ETF...
SpaceX's $800 Price Target Triggers Bubble Talk in Markets
Analysts publish an eyebrow-raising spacex’s $800 price target, implying a potential trillion-dollar leap in value an...
Eye-Catching Yield This Options Strategy for AMDY
Yield-focused investors have chased AMDY's eye-catching yield this options strategy promises. Yet the income is volat...
CTA Gains While Markets Collapse: What It Holds Now
As the S&P 500 faltered in early 2026, the Simplify Managed Futures Strategy ETF (CTA) posted gains, highlighting a h...
SharpLink’s Ethereum Just Generated a $686M Loss Sparks Debate
SharpLink reveals a hefty Q1 loss tied to unrealized Ethereum markdowns, prompting a debate over Galaxy Digital's fun...
This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Millie Bobby Brown Says: Smart Money Moves for Celeb Earnings
A recent celebrity confession grabs headlines, but the real takeaway is how fast income can rise and how to handle we...
Enviri Stock 120% Million Momentum: $43M Buy Shifts Holdings
A major institutional purchase has put Enviri in the spotlight. This article breaks down what the $43 million buy mea...
UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status